Cargando…
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
Contrast agents (CAs) play a crucial role in high-quality magnetic resonance imaging (MRI) applications. At present, as a result of the Gd-based CAs which are associated with renal fibrosis as well as the inherent dark imaging characteristics of superparamagnetic iron oxide nanoparticles, Mn-based C...
Autores principales: | Cai, Xiaoxia, Zhu, Qingxia, Zeng, Yun, Zeng, Qi, Chen, Xueli, Zhan, Yonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814316/ https://www.ncbi.nlm.nih.gov/pubmed/31695370 http://dx.doi.org/10.2147/IJN.S218085 |
Ejemplares similares
-
In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles
por: Zhan, Yonghua, et al.
Publicado: (2017) -
AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer
por: Li, Jingjing, et al.
Publicado: (2019) -
Aqueous Dispersion of Manganese–Zinc Ferrite Nanoparticles Protected by PEG as a T(2) MRI Temperature Contrast Agent
por: Lachowicz, Dorota, et al.
Publicado: (2023) -
Multimodal
Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional
Nanoparticles as Contrast Agents
por: Zhao, Ying, et al.
Publicado: (2020) -
Novel vinyl-modified RGD conjugated silica nanoparticles based on photo click chemistry for in vivo prostate cancer targeted fluorescence imaging
por: Li, Hanrui, et al.
Publicado: (2019)